UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.273-283

2017

Volltextzugriff (PDF)

B2 or not B2? That is the question: a review of periprosthetic fractures around cemented taper-slip femoral components

The bone & joint journal, 2021-01, Vol.103-B (1), p.71-78

2021

Volltextzugriff (PDF)

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.403-410

2016

Volltextzugriff (PDF)

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

Diabetic medicine, 2004-11, Vol.21 (11), p.1204-1212

2004

Volltextzugriff (PDF)

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.449-457

2017

Volltextzugriff (PDF)

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

Clinical therapeutics, 2007, Vol.29 (1), p.139-153

2007

Volltextzugriff (PDF)

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

Obesity (Silver Spring, Md.), 2004-04, Vol.12 (4), p.661-668

2004

Volltextzugriff (PDF)

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Diabetes care, 2002-04, Vol.25 (4), p.724-730

2002

Volltextzugriff (PDF)

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes : A 1-year randomized controlled trial

Diabetes care, 2003-03, Vol.26 (3), p.784-790

2003

Volltextzugriff (PDF)

Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9698), p.1351-1363

2009

Volltextzugriff (PDF)

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

Circulation (New York, N.Y.), 2024-03, Vol.149 (13), p.993-1003

2024

Volltextzugriff (PDF)

Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Diabetes care, 2024-04, Vol.47 (4), p.629-637

2024

Volltextzugriff (PDF)

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1998-02, Vol.128 (3), p.176

1998

Volltextzugriff (PDF)

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.76-81

2013

Volltextzugriff (PDF)

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

The Lancet infectious diseases, 2024-06, Vol.24 (6), p.581-593

2024

Volltextzugriff (PDF)

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: A dose-timing study

Diabetes care, 2003-11, Vol.26 (11), p.3074-3079

2003

Volltextzugriff (PDF)

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin

Diabetes/metabolism research and reviews, 2006-11, Vol.22 (6), p.483-491

2006

Volltextzugriff (PDF)

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

Vascular health and risk management, 2012-01, Vol.8 (default), p.255-264

2012

Volltextzugriff (PDF)

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study

Diabetes/metabolism research and reviews, 2004-01, Vol.20 (1), p.55-60

2004

Volltextzugriff (PDF)

Five-year results of a randomised controlled trial comparing mobile and fixed bearings in total knee replacement

The bone & joint journal, 2013-04, Vol.95-B (4), p.486-492

2013

Volltextzugriff (PDF)

Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets

Diabetes, obesity & metabolism, 2003-11, Vol.5 (6), p.408-414

2003

Volltextzugriff (PDF)

In-house referral: a primary care alternative to immediate secondary care referral?

Family practice, 1999-12, Vol.16 (6), p.558-561

1999

Volltextzugriff (PDF)

Mucosa associated lymphoma of the lung

Thorax, 1993-06, Vol.48 (6), p.670-672

1993

Volltextzugriff (PDF)

Neoadjuvant treatment of stage IIIA non-small cell lung cancer : long-term results

American journal of clinical oncology, 1994-02, Vol.17 (1), p.26-36

1994

Volltextzugriff (PDF)

Pure red cell aplasia heralding chronic myelomonocytic leukaemia

Clinical and laboratory haematology, 1989-01, Vol.11 (1), p.61-65

1989

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Female
(30)
Male
(29)
Middle Aged
(29)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Adult
(22)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Diabetes Mellitus, Type 2 - Drug Therapy
(9)
Drug Therapy, Combination
(7)
Endocrinology & Metabolism
(7)
Hypoglycemic Agents - Therapeutic Use
(7)
Islet Amyloid Polypeptide
(7)
Pharmacology. Drug Treatments
(7)
Adolescent
(6)
Amyloid - Adverse Effects
(6)
Blood Glucose - Drug Effects
(6)
Blood Glucose - Metabolism
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency

B2 or not B2? That is the question: a review of periprosthetic fractures around cemented taper-slip femoral components

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes : A 1-year randomized controlled trial

Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)

Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: A dose-timing study

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study

Five-year results of a randomised controlled trial comparing mobile and fixed bearings in total knee replacement

Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets

In-house referral: a primary care alternative to immediate secondary care referral?

Mucosa associated lymphoma of the lung

Neoadjuvant treatment of stage IIIA non-small cell lung cancer : long-term results

Pure red cell aplasia heralding chronic myelomonocytic leukaemia

Aktive Filter

Suchergebnisse filtern